{"schema_version":"alpha-profile-public-v1","slug":"faisal-g-sukhtian","canonical_url":"https://registry.alpha.ac/people/faisal-g-sukhtian","as_of":"2026-09-21T19:13:04.931257+00:00","published_at":"2026-09-02T02:37:23.727145+00:00","last_reviewed_at":"2026-05-16T01:41:42.19+00:00","identity":{"display_name":"Faisal G. Sukhtian","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Outlook Therapeutics, Inc.","company_slug":"outlook-therapeutics-inc","exchange":"NASDAQ","ticker":"OTLK","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2017-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","effective_date":"2026-01-26","last_checked_at":"2026-04-25T00:37:01.306+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=faisal-g-sukhtian","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=faisal-g-sukhtian&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Sukhtian has served as Chairman of the Board since January 2025 and as a Board member since September 2017. He is Executive Director at GMS Holdings with extensive experience in operations, strategy development and mergers and acquisitions in the biopharma and life sciences space. He has served as chairman of Genepharm since 2019 and previously worked at J.P. Morgan on M&A transactions."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Outlook Therapeutics, Inc.","organizationId":"outlook-therapeutics-inc","title":"Director","period":"2017-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Outlook Therapeutics, Inc.","company_slug":"outlook-therapeutics-inc","exchange":"NASDAQ","ticker":"OTLK","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2017-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","effective_date":"2026-01-26","last_checked_at":"2026-04-25T00:37:01.306+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Faisal G. Sukhtian as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.426824+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"Faisal G. Sukhtian currently serves as Chair at Outlook Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.382461+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Nominating/Governance","Executive"],"claim_text":"Faisal G. Sukhtian serves on Nominating/Governance, Executive.","claim_state":"verified","valid_from":"2026-01-26","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.405316+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"GMS Holdings","claim_text":"Faisal G. Sukhtian is linked to GMS Holdings as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.577977+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Executive Director","claim_text":"Faisal G. Sukhtian is also listed as Executive Director.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.55641+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Faisal G. Sukhtian as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.476274+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Faisal G. Sukhtian as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:41:42.448426+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"OTLK DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","published_at":"2026-01-26T00:00:00+00:00","last_checked_at":"2026-05-16T01:41:42.277319+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:faisal-g-sukhtian","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2017-01-01 · current","organization":"Outlook Therapeutics, Inc.","organization_id":"outlook-therapeutics-inc"},"claim_text":"Director at Outlook Therapeutics, Inc. (2017-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/faisal-g-sukhtian#profile","url":"https://registry.alpha.ac/people/faisal-g-sukhtian","dateModified":"2026-05-16T01:41:42.19+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/faisal-g-sukhtian#person","name":"Faisal G. Sukhtian","url":"https://registry.alpha.ac/people/faisal-g-sukhtian","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Outlook Therapeutics, Inc.","tickerSymbol":"NASDAQ: OTLK"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2017-01-01","memberOf":{"@type":"Organization","name":"Outlook Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/outlook-therapeutics-inc","tickerSymbol":"NASDAQ: OTLK"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","name":"OTLK DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/faisal-g-sukhtian"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T01:41:42.19+00:00","observed_at":"2026-09-21T19:13:04.931257+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"faisal-g-sukhtian","canonical_url":"https://registry.alpha.ac/people/faisal-g-sukhtian"},"publication":{"published_at":"2026-09-02T02:37:23.727145+00:00","last_reviewed_at":"2026-05-16T01:41:42.19+00:00","as_of":"2026-09-21T19:13:04.931257+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/faisal-g-sukhtian","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/faisal-g-sukhtian","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/faisal-g-sukhtian.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}